Liver resection <i>versus</i> transarterial chemoembolization plus PD-1 inhibitors and lenvatinib for hepatocellular carcinoma with portal vein tumour thrombus
The LRPL strategy was associated with superior survival compared with TPL, especially in patients with secondary branch PVTT, indicating its potential as the preferred therapeutic option for this patient population.
Authors
- Xiaotong Zhang (ORCID: https://orcid.org/0000-0002-9197-1421)
- Haitao Zhang (ORCID: https://orcid.org/0000-0002-1639-4089)
- Yue Wu (ORCID: https://orcid.org/0000-0002-9073-5988)
- Chu Luo
- Guandou Yuan (ORCID: https://orcid.org/0000-0002-4758-1928)
- Yongyi Zeng
- Changzhen Shang
- Wanguang Zhang
- Bin Guo
- Shaliheng Yerken
- Zhicheng Liu
- Shenjie Xie
- Enyu Liu
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Binzhou Medical University (CN)
- Sun Yat-sen University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Sun Yat-sen Memorial Hospital (CN)
- Mengchao Hepatobiliary Hospital (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Fujian Provincial Cancer Hospital (CN)
- Tongji Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Dezhou University (CN)
- Huazhong University of Science and Technology (CN)
- Hubei University (CN)
Publication Details
- Journal
- BJS Open
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1093/bjsopen/zrag007
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00